Talon Group Consulting
A Glimpse into our Portfolio of Work
How we help life science leaders design technology and AI strategies that drive revenue growth, margin improvement, and organizational readiness
Who we serve and why clients choose us
We partner with Fortune 500 and mid-to-large-cap life science companies in pharma, biotech, medical devices, and digital health.
Our clients include:
-
C-suite leaders setting enterprise or functional strategy
-
SVP/VP-level heads across R&D, clinical development, commercial, marketing, regulatory, medical affairs, and portfoli
-
Functional and business unit heads driving cross-functional alignment
They turn to us when they need:
-
Strategic clarity on where AI and technology fit in their roadmap
-
Investment decisions tied to revenue, margin, and risk outcome
-
Execution-ready strategies that move beyond pilots to realized business value
Learn more about:
How We Help: Turning Challenges Into Opportunities
We specialize in addressing high-impact pain points, such as:
​
-
Market uncertainty
Which therapeutic areas or regions to prioritize for investment or launch
-
Digital disruption
How to leverage AI, analytics, and digital health for commercial and R&D success
-
Organizational effectiveness
How to design operating models, governance structures, and capability strategies that position functions for sustained performance
-
Partnership ambiguity
How to evaluate, structure, and design high-value collaborations with technology and service providers
Our approach combines strategy lifecycle design, rigorous analysis, and a fit-for-purpose mindset, ensuring every strategy is validated by data, aligned with your objectives, and built for sustainable competitive advantage.
​
A few key examples of client engagements in our portfolio of work include:
Commercial Innovation and Strategy for Neuroscience Portfolio
Global F100 Life Sciences Client
-
Challenge:
Needed to evaluate market opportunities and develop a digital launch roadmap for a neuroscience portfolio.
-
Solution:
Conducted market sizing, segmentation, opportunity analysis, and digital product launch planning. Used analytics, scenario modeling, and journey mapping to identify three high-potential market segments and delineate a strategic roadmap.
-
Impact:
Enabled the client to prioritize investments, accelerate market penetration, and structure partnerships for sustained growth. Estimated added market value of up to $0.6B annually for existing markets and $1.8B for future launches.
Product Launch Market Prioritization for
Medical Device
Large Medical Device Multinational Corporation
​
-
Challenge:
Prioritizing global launch markets for a complex, innovative device.
-
Solution:
Developed a comprehensive market model, evaluated competitive dynamics and portfolio impacts, and identified optimal markets for revenue and unit sales.
-
Impact:
Provided a clear, data-driven roadmap for global launch, maximizing commercial potential and resource allocation.
Translational Medicine Performance Improvement
Top 10 Pharmaceutical Company
​
-
Challenge:
Rapid R&D pipeline growth led to operational bottlenecks and inefficiencies in project management, reagent procurement, and lab practices.
-
Solution:
Mapped workflows, implemented an integrated project management system, standardized lab practices, and negotiated vendor contracts.
-
Impact:
Streamlined project management, improved data quality, and enabled scalable R&D operations, supporting the organization’s growth and scientific excellence.
Clinical Data Management System Implementation
Leading Multinational Pharmaceutical Company
​
-
Challenge:
Disparate clinical data processes hindered data quality and regulatory reporting.
-
Solution:
Designed and implemented a scalable technology platform and global standards governance process for clinical data lifecycle management.
-
Impact:
Enhanced data integrity, compliance, and operational efficiency across global R&D functions.
Digital Health Strategy & Partnership Optimization for Diabetes Portfolio
Leading Multinational Pharmaceutical Company
-
Challenge:
Maximizing unit sales and long-term value through digital health partnerships.
-
Solution:
Assessed and optimized partnership structures, mapped patient and HCP journeys, and developed a data-driven framework for partnership evaluation using real-world data.
-
Impact:
Prioritized and structured digital health partnerships that improved patient engagement and aligned with strategic objectives, validated through pilot programs and measurable KPIs.
Technology Assessment and Commercial Strategy for MedTech Start-Up
Medical Device Start-Up
-
Challenge:
Defining the commercial and technological direction for a novel blood coagulation monitoring device.
-
Solution:
Conducted technology assessment, patient segmentation, HCP journey mapping, and competitive landscape analysis. Developed a strategic roadmap for commercialization and innovation.
-
Impact:
Provided actionable guidance on market entry, partnership selection, and technology positioning, supporting successful product development and launch.
Organizations we have worked with
